Strange Tony,
Humana CEO Bruce Broussard informed Wall Street analysts of plans to build a longitudinal health record.
This year, we'll be bringing on all of Kindred in that relationship as a result of them completing their EMR install.
In the home, we advanced our transformational home health initiative with Kindred at Home and Curo through the implementation of a company-wide EMR and the extrapolation of best practices for our [indiscernible] over 20,000 home health episodes.
The next phase beginning in 2020 is to provide more care services in the home, including acute care and primary care in the home, so that we may begin to generate meaningful trend vendors for our health plans in the future while improving clinical outcomes for our seniors.Homecare Homebase's cumbersome, complex software requires multiple workarounds. It turned into "garbage in/garbage out" as nurses refuse to check any boxes that might take them on a clinical rabbit trail. The narrative summary is the only place to find pertinent clinical information. It resides nowhere else in HCHB's twisted bowels.
On measure after measure our hospice is far worse under Broussard's greedy leadership. Humana implemented a littany of worst practices. The system robs staff of fair pay for hours worked and miles driven. That is not a best practice. It's abusive.
Humana CFO Brian Kane mentioned Kindred at Home several times in the recent earnings call with Wall Street analysts.
For Healthcare Services, we had a strong year as we saw growth in our pharmacy business, solid performance of Kindred at Home and continued improvement in our Conviva operations, partially offset by the cost incurred to continue to expand our owned JV and Alliance senior-focused primary care centers.I'm not sure what else Brian Kane can do to drive EBITDA growth. Humana and its financial rapscallion partners already depopulated our hospice staff. Caring people quit or were targeted for elimination by the Mean Girl managers, local and regional.
Our home business is also anticipated to perform well led by Kindred at Home in which the conversion to Homecare Homebase across home health and hospice in 2019 weighed on results due to the significant required one-time investment, but will drive EBITDA in 2020.
Kindred at Home is also performing well. We hope to continue to see strong EBITDA growth, not withstanding the change in the payment model.
Humana executives want higher earnings and Medicare Advantage cost savings from Kindred at Home. Greedy executives rely on complex, unreliable technology while abusing actual caregivers. Broussard and Kane want profit growth and they don't care who gets hurt in that pursuit.
Anonymous